Royal Bank Of Canada Oncolytics Biotech Inc Transaction History
Royal Bank Of Canada
- $425 Billion
- Q2 2024
A detailed history of Royal Bank Of Canada transactions in Oncolytics Biotech Inc stock. As of the latest transaction made, Royal Bank Of Canada holds 62,267 shares of ONCY stock, worth $61,644. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,267
Previous 61,033
2.02%
Holding current value
$61,644
Previous $64,000
4.69%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ONCY
# of Institutions
43Shares Held
1.31MCall Options Held
0Put Options Held
0-
International Assets Investment Management, LLC Orlando, FL198KShares$196,4160.02% of portfolio
-
Seeds Investor LLC New York, NY190KShares$188,0410.1% of portfolio
-
Morgan Stanley New York, NY139KShares$137,1350.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il137KShares$135,7140.0% of portfolio
-
Goldman Sachs Group Inc New York, NY83.6KShares$82,7620.0% of portfolio
About ONCOLYTICS BIOTECH INC
- Ticker ONCY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 57,867,400
- Market Cap $57.3M
- Description
- Oncolytics Biotech Inc., a development-stage biopharmaceutical company, focuses on the discovery and development of pharmaceutical products for the treatment of cancer. Its lead product is pelareorep, an intravenously delivered immunotherapeutic agent for the treatment of solid tumors and hematological malignancies. Oncolytics Biotech Inc. has a...